GPATCH8 inhibitors are small molecules or compounds that specifically interact with and inhibit the activity of the GPATCH8 protein. GPATCH8 is a member of the G-patch domain-containing protein family, characterized by a conserved glycine-rich region known as the G-patch domain. This domain is typically involved in RNA binding and associated processes, such as RNA splicing, processing, and metabolism. The inhibition of GPATCH8 can be achieved through molecules designed to target its functional domains or by disrupting its interaction with RNA or other proteins. By blocking GPATCH8 activity, these inhibitors can influence cellular pathways related to RNA dynamics and post-transcriptional regulation.
The specificity of GPATCH8 inhibitors lies in their ability to modulate this protein's interactions with RNA-binding complexes. Such inhibitors are often developed to explore the mechanistic roles of GPATCH8 in fundamental biological processes. The G-patch domain's unique structure presents opportunities for the design of molecules that can tightly bind and obstruct its function. Studies on GPATCH8 inhibitors are crucial for understanding the broader regulatory networks involving RNA-binding proteins and their roles in gene expression, splicing regulation, and cellular homeostasis. Additionally, GPATCH8 inhibitors serve as useful tools in molecular biology to dissect RNA processing events, providing insights into the protein's exact contribution to the regulation of RNA metabolism and related cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
A splicing inhibitor that can disrupt spliceosome function, potentially affecting GPATCH8-related RNA splicing processes. | ||||||
SRPIN 340 | 218156-96-8 | sc-394310 | 10 mg | $226.00 | 1 | |
A selective inhibitor of serine-arginine protein kinases, which can modulate splicing factors, potentially impacting GPATCH8 function. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
A selective inhibitor of splicing factor 3B subunit 1 (SF3B1), which can affect spliceosome assembly, potentially impacting GPATCH8 activity. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
A pre-mRNA splicing inhibitor that can disrupt splicing events, potentially affecting GPATCH8 function in RNA processing. | ||||||
Madrasin | 374913-63-0 | sc-507563 | 100 mg | $750.00 | ||
A small molecule that can modulate splicing, potentially altering the biological processes GPATCH8 is involved in. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
A compound that interferes with spliceosome assembly, which can impact GPATCH8-mediated processing of RNA. | ||||||